Daraxonrasib is effective for patients with RAS-mutant and other metastatic pancreatic ductal adenocarcinomas (mPDACs), ...
ASCO 2026: PSMAddition shows 177Lu-PSMA-617 boosts rPFS across mHSPC subgroups, with steady safety and insights on PSMA PET ...
An investigational peptide receptor radionuclide therapy showed a manageable safety profile in patients. The therapy showed ...
Two nights before the data were announced, “transformative” was the word used to describe the results for RASolute 302 ...
According to information provided by her family to the media, Marcia Lucas died on Friday at the age of 80 from metastatic ...
A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who ...
The singer, songwriter, and producer helped soundtrack the 1970s as both a solo artist and member of the legendary family ...
Foster Sylvers, the child singer in The Sylvers whose voice helped propel the family R&B group to stardom in the 1970s, has ...
One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy induced rapid, deep and durable systemic ...
The physician says she is worried about the rise in early-onset tumors and laments inequalities between countries in access ...
First-ever immunotherapy combination approved in Europe for adult and adolescent patients, ages 12 and older, with previously untreated Stage III or IV classical Hodgkin Lymphoma (cHL) “For patients ...
Immuneering Corporation ( IMRX) Discusses Positive Atebimetinib ASCO Data Update in First-Line Pancreatic Cancer June 1, 2026 8:00 AM EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results